Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 1 The patient characteristics

From: The impact of ageing on the distribution of preformed anti-HLA and anti-MICA antibody specificities in recipients from eastern China prior to initial HSCT

 

Group

Transfusion

Pregnancy

Patients (n = 426)

Age

 ≤ 30 years

76(62.3%)

31(25.4%)

Male 74(17.4%)

Female 48(11.3%)

31–50 years

118(67.0%)

72(40.9%)

Male78 (18.3%)

Female 98(23.0%)

 ≥ 51 years

98(76.6%)

53(41.4%)

Male 75 (17.6%)

Female 53(12.4%)

Diagnosis

AML(Acute myeloid leukemia)

121(28.4%)

ALL(Acute lymphoblastic leukemia)

72(16.9%)

MDS(Myelodysplastic syndromes)

67(15.7%)

CMML(Chronic myelomonocytic leukemia)

52(12.2%)

AA (Aplastic anemia)

35(8.2%)

Others

79(18.5%)

Back to article page

Immunity & Ageing

ISSN: 1742-4933

Contact us